These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 33367557)

  • 1. Lysophosphatidic acid mediated PI3K/Akt activation contributed to esophageal squamous cell cancer progression.
    Liu S; Jiang H; Min L; Ning T; Xu J; Wang T; Wang X; Zhang Q; Cao R; Zhang S; Zhu S
    Carcinogenesis; 2021 Apr; 42(4):611-620. PubMed ID: 33367557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysophosphatidic acid promotes ESCC progression by increasing the level of CCL2 secreted by esophageal epithelial cells.
    Ma H; Ma X; Qi L; Zhang Q; Wang T; Guo Q; Li P; Zhang S; Liu S
    J Gene Med; 2024 Jun; 26(6):e3708. PubMed ID: 38837511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADSCs and adipocytes are the main producers in the autotaxin-lysophosphatidic acid axis of breast cancer and healthy mammary tissue in vitro.
    Schmid R; Wolf K; Robering JW; Strauß S; Strissel PL; Strick R; Rübner M; Fasching PA; Horch RE; Kremer AE; Boos AM; Weigand A
    BMC Cancer; 2018 Dec; 18(1):1273. PubMed ID: 30567518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysophosphatidic Acid Induces Ligamentum Flavum Hypertrophy Through the LPAR1/Akt Pathway.
    Zhou T; Du L; Chen C; Han C; Li X; Qin A; Zhao C; Zhang K; Zhao J
    Cell Physiol Biochem; 2018; 45(4):1472-1486. PubMed ID: 29466791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autotaxin Regulates Maintenance of Ovarian Cancer Stem Cells through Lysophosphatidic Acid-Mediated Autocrine Mechanism.
    Seo EJ; Kwon YW; Jang IH; Kim DK; Lee SI; Choi EJ; Kim KH; Suh DS; Lee JH; Choi KU; Lee JW; Mok HJ; Kim KP; Matsumoto H; Aoki J; Kim JH
    Stem Cells; 2016 Mar; 34(3):551-64. PubMed ID: 26800320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysophosphatidic Acid Mediates Imiquimod-Induced Psoriasis-like Symptoms by Promoting Keratinocyte Proliferation through LPAR1/ROCK2/PI3K/AKT Signaling Pathway.
    Kim D; Kim HJ; Baek JO; Roh JY; Jun HS
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autotaxin-LPA axis regulates hMSC migration by adherent junction disruption and cytoskeletal rearrangement via LPAR1/3-dependent PKC/GSK3β/β-catenin and PKC/Rho GTPase pathways.
    Ryu JM; Han HJ
    Stem Cells; 2015 Mar; 33(3):819-32. PubMed ID: 25376707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity and clinical relevance of autotaxin and lysophosphatidic acid pathways in high-grade serous carcinoma.
    Onallah H; Catane LJ; Tropé CG; Hetland Falkenthal TE; Reich R; Davidson B
    Virchows Arch; 2018 Oct; 473(4):463-470. PubMed ID: 30032361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autotaxin and LPA receptors represent potential molecular targets for the radiosensitization of murine glioma through effects on tumor vasculature.
    Schleicher SM; Thotala DK; Linkous AG; Hu R; Leahy KM; Yazlovitskaya EM; Hallahan DE
    PLoS One; 2011; 6(7):e22182. PubMed ID: 21799791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LPA receptor 1 mediates LPA-induced ovarian cancer metastasis: an in vitro and in vivo study.
    Yu X; Zhang Y; Chen H
    BMC Cancer; 2016 Nov; 16(1):846. PubMed ID: 27809800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of Rictor enhances cell sensitivity to PI3K inhibitor LY294002 by blocking mTORC2-medicated phosphorylation of Akt/PRAS40 in esophageal squamous cell carcinoma.
    Hou G; Zhao Q; Zhang M; Fan T; Liu M; Shi X; Ren Y; Wang Y; Zhou J; Lu Z
    Biomed Pharmacother; 2018 Oct; 106():1348-1356. PubMed ID: 30119206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of lysophosphatidic acid pathway modulators as therapies for fibrosis.
    Budd DC; Qian Y
    Future Med Chem; 2013 Oct; 5(16):1935-52. PubMed ID: 24175745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysophosphatidic acid and sphingosine 1-phosphate metabolic pathways and their receptors are differentially regulated during decidualization of human endometrial stromal cells.
    Brünnert D; Sztachelska M; Bornkessel F; Treder N; Wolczynski S; Goyal P; Zygmunt M
    Mol Hum Reprod; 2014 Oct; 20(10):1016-25. PubMed ID: 24994816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RIT1 suppresses esophageal squamous cell carcinoma growth and metastasis and predicts good prognosis.
    Feng YF; Lei YY; Lu JB; Xi SY; Zhang Y; Huang QT; Wu QL; Wang F
    Cell Death Dis; 2018 Oct; 9(11):1085. PubMed ID: 30348939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATX‑LPA axis facilitates estrogen‑induced endometrial cancer cell proliferation via MAPK/ERK signaling pathway.
    Zhang G; Cheng Y; Zhang Q; Li X; Zhou J; Wang J; Wei L
    Mol Med Rep; 2018 Mar; 17(3):4245-4252. PubMed ID: 29328374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promotion of cell-invasive activity through the induction of LPA receptor-1 in pancreatic cancer cells.
    Fukushima K; Otagaki S; Takahashi K; Minami K; Ishimoto K; Fukushima N; Honoki K; Tsujiuchi T
    J Recept Signal Transduct Res; 2018 Aug; 38(4):367-371. PubMed ID: 30396320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway.
    Wang H; Yang X; Guo Y; Shui L; Li S; Bai Y; Liu Y; Zeng M; Xia J
    J Exp Clin Cancer Res; 2019 Jul; 38(1):324. PubMed ID: 31331361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear Localization of DNAJB6 Is Associated With Survival of Patients With Esophageal Cancer and Reduces AKT Signaling and Proliferation of Cancer Cells.
    Yu VZ; Wong VC; Dai W; Ko JM; Lam AK; Chan KW; Samant RS; Lung HL; Shuen WH; Law S; Chan YP; Lee NP; Tong DK; Law TT; Lee VH; Lung ML
    Gastroenterology; 2015 Dec; 149(7):1825-1836.e5. PubMed ID: 26302489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Autotaxin-Lysophosphatidic Acid Axis Promotes Lung Carcinogenesis.
    Magkrioti C; Oikonomou N; Kaffe E; Mouratis MA; Xylourgidis N; Barbayianni I; Megadoukas P; Harokopos V; Valavanis C; Chun J; Kosma A; Stathopoulos GT; Bouros E; Bouros D; Syrigos K; Aidinis V
    Cancer Res; 2018 Jul; 78(13):3634-3644. PubMed ID: 29724718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysophosphatidic acid receptor expression and function in human hepatocellular carcinoma.
    Sokolov E; Eheim AL; Ahrens WA; Walling TL; Swet JH; McMillan MT; Simo KA; Thompson KJ; Sindram D; McKillop IH
    J Surg Res; 2013 Mar; 180(1):104-13. PubMed ID: 23182454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.